Preferred Label : Hypocalcemia, autosomal dominant 1;
Symbol : HYPOC1;
CISMeF acronym : HYPOC1;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Hypercalciuric hypocalcemia; Hypocalcemia, familial;
Included titles and symbols : Hypocalcemia, autosomal dominant 1, with bartter syndrome;
Description : Autosomal dominant hypocalcemia-1 is associated with low or normal serum parathyroid
hormone concentrations (PTH). Approximately 50% of patients have mild or asymptomatic
hypocalcemia; about 50% have paresthesias, carpopedal spasm, and seizures; about 10%
have hypercalciuria with nephrocalcinosis or kidney stones; and more than 35% have
ectopic and basal ganglia calcifications (summary by Nesbit et al., 2013). Thakker
(2001) noted that patients with gain-of-function mutations in the CASR gene, resulting
in generally asymptomatic hypocalcemia with hypercalciuria, have low-normal serum
PTH concentrations and have often been diagnosed with hypoparathyroidism because of
the insensitivity of earlier PTH assays. Because treatment with vitamin D to correct
the hypocalcemia in these patients causes hypercalciuria, nephrocalcinosis, and renal
impairment, these patients need to be distinguished from those with other forms of
hypoparathyroidism (see 146200). Thakker (2001) suggested the designation 'autosomal
dominant hypocalcemic hypercalciuria' for this CASR-related disorder. - Genetic Heterogeneity
of Autosomal Dominant Hypocalcemia Autosomal dominant hypocalcemia-2 (HYPOC2; 615361)
is caused by mutation in the GNA11 gene (139313) on chromosome 19p13.;
Inheritance : Autosomal dominant;
Molecular basis : Caused by mutation in the calcium-sensing receptor gene (CASR, 601199.0004);
Prefixed ID : #601198;
Origin ID : 601198;
UMLS CUI : C3715128;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)